Valuation: Kenvue Inc.

Market Cap 37.54B 32.51B 30.31B 27.87B 52.62B 3,569B 53.21B 356B 140B 1,786B 141B 138B 5,915B P/E 2026 *
20.6x
P/E 2027 * 18.2x
Enterprise Value 44.94B 38.92B 36.28B 33.37B 63B 4,273B 63.71B 426B 167B 2,138B 169B 165B 7,082B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.77x
Free-Float
98.9%
Yield 2026 *
4.33%
Yield 2027 * 4.42%
1 day-0.41%
1 week-0.61%
Current month+2.23%
1 month+0.56%
3 months+13.24%
6 months+8.85%
Current year+14.03%
1 week 18.68
Extreme 18.685
19.77
1 month 18.58
Extreme 18.58
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.96
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
2/13/26 Fiscal year

Chief Operating Officer

64,111 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-0.61%-9.10%-16.44% 37.54B
-0.82%+0.47%-2.47%-6.46% 345B
+0.54%-4.48%-5.61%+3.74% 137B
+0.81%-0.22%+12.30%+21.30% 73.76B
-0.53%+3.09%-18.02%-18.10% 51.78B
-0.01%+3.36%-4.36%-48.89% 31.47B
+5.12%+1.99%-24.17%-31.21% 19.68B
+1.98%+0.75%+17.11%+10.86% 19.68B
-0.87%-3.98%-7.03%+14.72% 18.47B
+1.02%+0.20%-14.44%+5.06% 11.38B
Average +0.54%-1.06%-5.58%-6.54% 74.59B
Weighted average by Cap. -0.37%-1.97%-3.43%-4.43%

Financials

2026 *2027 *
Net sales 15.63B 13.53B 12.62B 11.6B 21.9B 1,486B 22.15B 148B 58.18B 743B 58.69B 57.39B 2,462B 16.01B 13.87B 12.93B 11.89B 22.45B 1,523B 22.7B 152B 59.62B 762B 60.14B 58.81B 2,523B
Net income 1.83B 1.59B 1.48B 1.36B 2.57B 174B 2.59B 17.36B 6.82B 87.08B 6.87B 6.72B 288B 2.07B 1.79B 1.67B 1.54B 2.9B 197B 2.94B 19.65B 7.71B 98.52B 7.78B 7.61B 326B
Net Debt 7.41B 6.41B 5.98B 5.5B 10.38B 704B 10.5B 70.27B 27.58B 352B 27.82B 27.2B 1,167B 6.81B 5.9B 5.5B 5.06B 9.55B 648B 9.65B 64.62B 25.36B 324B 25.58B 25.02B 1,073B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-05 US$19.67 +0.61% 28,417,140
26-08-04 US$19.55 +2.84% 23,595,514
26-08-03 US$19.01 -1.20% 35,167,488
26-07-31 US$19.24 -0.36% 22,744,382
26-07-30 US$19.31 -2.43% 16,297,221
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.55USD
Average target price
19.83USD
Spread / Average Target
+1.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock